Download Free Sample Report

The Global "Genomics Solutions Market" was valued at USD 19.78 Billion in 2024 and is projected to reach USD 29.19 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period (2024-2030).

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Genomics solutions refer to technologies and approaches used to study and analyze an organism's complete set of DNA (its genome). These solutions include sequencing technologies, bioinformatics tools, and applications in medicine, agriculture, and environmental science aimed at understanding genetic information and its impact on biological systems.

• Influence of COVID-19: The estimation of market sizes includes the impact of the COVID-19 pandemic, which has accelerated genomic research and diagnostics to understand and combat the virus.

• Impact of the Russia-Ukraine War: The ongoing conflict between Russia and Ukraine has been considered in the market analysis, potentially affecting funding, international collaborations, and supply chain stability in genomics research and applications.

• Drivers of Growth: Key drivers of market growth include increasing demand for personalized medicine, advancements in genomic technologies, rising prevalence of genetic disorders, and growing investment in research and development.

• Technological Advancements: Innovations in next-generation sequencing (NGS), CRISPR gene editing, and bioinformatics are enhancing the capabilities and applications of genomics solutions.

• Government and Healthcare Policies: Supportive government policies and healthcare initiatives promoting genomic research and personalized medicine are expected to drive market growth.

• Challenges: Market growth faces challenges such as high costs of genomic technologies, data privacy and ethical concerns, and the need for skilled professionals in genomics.

• Regional Insights: North America and Europe are anticipated to hold significant market shares due to advanced healthcare infrastructure, high investment in research, and early adoption of genomic technologies, while the Asia-Pacific region is projected to witness substantial growth driven by increasing healthcare investments and improving awareness.

The global key manufacturers of Genomics Solutions include 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. in 2024, the global top five players have a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Genomics Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Solutions. This report contains market size and forecasts of Genomics Solutions in global, including the following market information:

• Global Genomics Solutions Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global top five companies in 2024 (%)

We has surveyed the Genomics Solutions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomics Solutions Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Genomics Solutions Market Segment Percentages, by Type, 2024 (%)

• Nucleic Acids Extraction and QC
• Gene Expression Services
• Genotyping Services and Pharmacogenomics
• Data Analysis and Interpretation
• Others

Global Genomics Solutions Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Genomics Solutions Market Segment Percentages, by Application, 2024 (%)

• Hospitals and Clinics
• Pharmaceutical
• Research Institutes
• Agrochemical
• Chemical
• Others

Global Genomics Solutions Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Genomics Solutions Market Segment Percentages, By Region and Country, 2024 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Genomics Solutions revenues in global market, 2019-2024 (estimated), ($ millions)
• Key companies Genomics Solutions revenues share in global market, 2024 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 10X Genomics Inc.
• Abcam Plc
• Exeter Clinical Laboratory
• Psomagen
• BGI Genomics Co. Ltd.
• Bio Rad Laboratories Inc.
• Danaher Corp.
• Eppendorf AG
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• CD Genomics
• Illumina
• qGenomics
• IQVIA
• Beckman Coulter
• Including or Excluding key companies relevant to your analysis.